BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Wright Medical Group N.V. to Host Fourth Quarter 2017 Earnings Conference Call

  Operating results will be released at 3:00 p.m. Central Time that day.

  February 6, 2018

   · 

  1 min read
• Resolutions of Extraordinary General Meeting of Fit Biotech Oy February 6, 2018

  The EGM of FIT Biotech Oy (“FIT Biotech”, “Company”) has made the following resolutions today:

  February 6, 2018

   · 

  11 min read
• Business

  Bio-Rad to Report Fourth-Quarter and Full-Year 2017 Financial Results Tuesday, February 27, 2018

  Bio-Rad will report financial results for the fourth quarter and full year 2017 on Tuesday, February 27, 2018, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

  February 6, 2018

   · 

  1 min read
• Genetown

  BeiGene Announces Commercial Availability of VIDAZA (Azacitidine for Injection) in China

  The drug is marketed in China by BeiGene under an exclusive license from Celgene Corporation.

  February 6, 2018

   · 

  7 min read
• Bioasis to Present at the 20th Annual BIO CEO & Investor Conference

  Bioasis Technologies, Inc. announced today that it will present at the 20th Annual BIO CEO & Investor Conference, to be held February 12-13, 2018 at the New York Marriott Marquis.

  February 6, 2018

   · 

  5 min read
• Pharm Country

  New Knockout and Knockdown Validated Antibodies Are Launched by Creative Diagnostics for Bio-researchers

  Knockout validation has been developed as a part of Creative Diagnostics’ standard antibody validation, and knockout validated antibodies are available at Creative Diagnostics.

  February 6, 2018

   · 

  2 min read
• Policy

  TraceLink Dismisses Litigation Claims Against Healthcare Distribution Alliance (HDA)

  TraceLink agreed to the dismissal as they have resolved the misunderstandings that led to their dispute.

  February 6, 2018

   · 

  3 min read
• QIAGEN Launches Predictive Therascreen Pitx2 Test in Europe to Guide Treatment in High-Risk Breast Cancer

  QIAGEN announced the European launch of its novel therascreen PITX2 RGQ PCR Kit, the first clinically validated DNA methylation assay that helps predict the response of certain high-risk breast cancer patients to anthracycline-based chemotherapy.

  February 6, 2018

   · 

  2 min read
• Business

  Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results

  tSeattle Genetics today reported financial results for the fourth quarter and year ended December 31, 2017.

  February 6, 2018

   · 

  19 min read
• Business

  TherapeuticsMD to Host Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast on February 20

  The conference call and webcast will take place at 4:30 p.m. Eastern Time (ET).

  February 6, 2018

   · 

  4 min read